These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26143621)

  • 21. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine.
    Silva MC; Haggarty SJ
    Ann N Y Acad Sci; 2020 Jul; 1471(1):18-56. PubMed ID: 30875083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons.
    Engle SJ; Blaha L; Kleiman RJ
    Neuron; 2018 Nov; 100(4):783-797. PubMed ID: 30465765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of region-specific and high-purity neurons from human feeder-free iPSCs.
    Sato T; Imaizumi K; Watanabe H; Ishikawa M; Okano H
    Neurosci Lett; 2021 Feb; 746():135676. PubMed ID: 33516803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conducting Polymer Mediated Electrical Stimulation Induces Multilineage Differentiation with Robust Neuronal Fate Determination of Human Induced Pluripotent Stem Cells.
    Tomaskovic-Crook E; Gu Q; Rahim SNA; Wallace GG; Crook JM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons.
    Liu X; Campanac E; Cheung HH; Ziats MN; Canterel-Thouennon L; Raygada M; Baxendale V; Pang AL; Yang L; Swedo S; Thurm A; Lee TL; Fung KP; Chan WY; Hoffman DA; Rennert OM
    Mol Neurobiol; 2017 Aug; 54(6):4507-4523. PubMed ID: 27356918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete neural stem cell (NSC) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism.
    Bifari F; Dolci S; Bottani E; Pino A; Di Chio M; Zorzin S; Ragni M; Zamfir RG; Brunetti D; Bardelli D; Delfino P; Cattaneo MG; Bordo R; Tedesco L; Rossi F; Bossolasco P; Corbo V; Fumagalli G; Nisoli E; Valerio A; Decimo I
    Pharmacol Res; 2020 Aug; 158():104863. PubMed ID: 32407957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder.
    Reis de Assis D; Szabo A; Requena Osete J; Puppo F; O'Connell KS; A Akkouh I; Hughes T; Frei E; A Andreassen O; Djurovic S
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.
    Liu YN; Lu SY; Yao J
    Psychiatry Clin Neurosci; 2017 Sep; 71(9):579-599. PubMed ID: 28393474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
    M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
    Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical Neurogenesis in Induced Pluripotent Stem Cells From Autistic Individuals.
    Adhya D; Swarup V; Nagy R; Dutan L; Shum C; Valencia-Alarcón EP; Jozwik KM; Mendez MA; Horder J; Loth E; Nowosiad P; Lee I; Skuse D; Flinter FA; Murphy D; McAlonan G; Geschwind DH; Price J; Carroll J; Srivastava DP; Baron-Cohen S
    Biol Psychiatry; 2021 Mar; 89(5):486-496. PubMed ID: 32826066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.
    Hazim RA; Karumbayaram S; Jiang M; Dimashkie A; Lopes VS; Li D; Burgess BL; Vijayaraj P; Alva-Ornelas JA; Zack JA; Kohn DB; Gomperts BN; Pyle AD; Lowry WE; Williams DS
    Stem Cell Res Ther; 2017 Oct; 8(1):217. PubMed ID: 28969679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders.
    Lee KM; Hawi ZH; Parkington HC; Parish CL; Kumar PV; Polo JM; Bellgrove MA; Tong J
    Mol Psychiatry; 2020 Feb; 25(2):368-378. PubMed ID: 31455859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of reprogrammed patient cells to investigate the etiology of neurological and psychiatric disorders.
    Christian KM; Song H; Ming GL
    Front Biol (Beijing); 2012 Jun; 7(3):179-188. PubMed ID: 34603405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Spinal Motor Neurons from Human Pluripotent Stem Cells.
    Santos DP; Kiskinis E
    Methods Mol Biol; 2017; 1538():53-66. PubMed ID: 27943183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Cortical Neuron Generation Using Cell Reprogramming: A Review of Recent Advances.
    McCaughey-Chapman A; Connor B
    Stem Cells Dev; 2018 Dec; 27(24):1674-1692. PubMed ID: 30343634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
    Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
    Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling neurological disorders by human induced pluripotent stem cells.
    Kunkanjanawan T; Noisa P; Parnpai R
    J Biomed Biotechnol; 2011; 2011():350131. PubMed ID: 22162635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia.
    Jacobs BM
    Schizophr Res; 2015 Oct; 168(1-2):563-8. PubMed ID: 26194993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.